The Richmond Laboratory confirmed today that after approval in Moscow to the batches shipped in April, it will be able to begin manufacturing the Sputnik Vida vaccine against the coronavirus. “As announced in due course, this is a continuous process with multiple stages that have been satisfactorily completed,” marcelo Figueiras’ company reported.
Vaccines manufactured by the Richmond Laboratory approved the institute’s quality control Gamaleya.Se argentina’s Sputnik V is coming, a new source of pride for our science and industry — Cecilia Nicolini (@cecilianicolini)
June 2, 2021
This day was marked by the notification of the Gamaleya Institute that approved under its quality standards the transfer of technology carried out with Richmond.” In the coming days, once the regulatory requirements have been met, production will begin to make available to Argentines a significant number of vaccines,” the laboratory added.
The hope in the national government, following this breakthrough with the Gamaleya Institute, is that vaccines produced in the country will be available for use in July. Meanwhile, the eighteenth flight of Aerolineas Argentinas arrived today in Moscow in search of 800 thousand doses of Sputnik V vaccines for the immunization plan against COVID-19.
The Richmond Laboratory statement
In the statement, the laboratory thanked the “Ministry of Health of the Nation, the body of professionals that make up ANMAT and the entire team involved for accompanying and supporting these complex health and production processes.”
